Cachexia: a therapeutic approach beyond cytokine antagonism
- 1 September 2002
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 85 (1) , 173-183
- https://doi.org/10.1016/s0167-5273(02)00245-0
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Molecular Regulation of Muscle Cachexia: It May Be More Than the ProteasomeBiochemical and Biophysical Research Communications, 2002
- Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factorBritish Journal of Surgery, 2000
- Loss of bone mineral in patients with cachexia due to chronic heart failureThe American Journal of Cardiology, 1999
- Termination of Acute-Phase ResponseGeneral Pharmacology: The Vascular System, 1998
- Elevated soluble CD14 receptors and altered cytokines in chronic heart failureThe American Journal of Cardiology, 1997
- Ubiquitin Gene Expression in Skeletal Muscle Is Increased During Sepsis: Involvement of TNF-α but Not IL-1Biochemical and Biophysical Research Communications, 1995
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Journal of Clinical Investigation, 1994
- The acute phase responseImmunology Today, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993